AU2003214725A1 - Preventing and/or treating cardiovascular disease and/or associated heart failure - Google Patents

Preventing and/or treating cardiovascular disease and/or associated heart failure

Info

Publication number
AU2003214725A1
AU2003214725A1 AU2003214725A AU2003214725A AU2003214725A1 AU 2003214725 A1 AU2003214725 A1 AU 2003214725A1 AU 2003214725 A AU2003214725 A AU 2003214725A AU 2003214725 A AU2003214725 A AU 2003214725A AU 2003214725 A1 AU2003214725 A1 AU 2003214725A1
Authority
AU
Australia
Prior art keywords
preventing
heart failure
cardiovascular disease
treating cardiovascular
associated heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003214725A
Inventor
John Richard Baker
Garth James Smith Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protemix Corp Ltd
Original Assignee
Protemix Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protemix Corp Ltd filed Critical Protemix Corp Ltd
Publication of AU2003214725A1 publication Critical patent/AU2003214725A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU2003214725A 2002-08-20 2003-03-17 Preventing and/or treating cardiovascular disease and/or associated heart failure Abandoned AU2003214725A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NZ52089602 2002-08-20
NZ52089502 2002-08-20
NZ520896 2002-08-20
NZ520895 2002-08-20
NZ52089702 2002-08-20
NZ520897 2002-08-20
PCT/NZ2003/000047 WO2004017957A1 (en) 2002-08-20 2003-03-17 Preventing and/or treating cardiovascular disease and/or associated heart failure

Publications (1)

Publication Number Publication Date
AU2003214725A1 true AU2003214725A1 (en) 2004-03-11

Family

ID=31950468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003214725A Abandoned AU2003214725A1 (en) 2002-08-20 2003-03-17 Preventing and/or treating cardiovascular disease and/or associated heart failure

Country Status (2)

Country Link
AU (1) AU2003214725A1 (en)
WO (1) WO2004017957A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018392A1 (en) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
ES2386782T3 (en) 2002-03-08 2012-08-30 Philera New Zealand Limited Prevention and / or treatment of cardiovascular disease and / or associated heart failure
MXPA05002883A (en) 2002-08-20 2005-10-05 Protemix Corp Ltd Dosage forms and related therapies.
JP2007505158A (en) * 2003-05-21 2007-03-08 ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム Inhibition of protein kinase C-μ (PKD) as a treatment for cardiac hypertrophy and heart failure
ES2304692T3 (en) 2004-02-04 2008-10-16 Nycomed Gmbh DERIVATIVES OF 2- (PIPERIDIN-4-IL) -4,5-DIHIDRO-2H-PIRIDAZIN-3-ONA AS PDE4 INHIBITORS.
AU2005281353A1 (en) 2004-07-19 2006-03-16 Philera New Zealand Limited Synthesis of triethylenetetramines
WO2006068516A1 (en) * 2004-12-20 2006-06-29 Protemix Corporation Limited Implantable medical devices coated with or containing copper chelating compounds
WO2006104401A1 (en) * 2005-03-26 2006-10-05 Protemix Corporation Limited Copper antagonist compositions
WO2006104402A1 (en) * 2005-03-26 2006-10-05 Protemix Corporation Limited Copper antagonist compositions
WO2006104400A1 (en) * 2005-03-26 2006-10-05 Protemix Corporation Limited Copper antagonist compositions
AU2006240568A1 (en) * 2005-04-25 2006-11-02 Philera New Zealand Limited Copper regulation evaluation and therapy
AU2006312407A1 (en) * 2005-11-09 2007-05-18 Philera New Zealand Limited Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits
EP2578221A1 (en) * 2011-10-04 2013-04-10 Magnus Intellectual Property Ltd. The therapeutic use of tetrathiomolybdate
US10478455B2 (en) 2010-03-30 2019-11-19 Ucl Business Ltd Therapeutic use of tetrathiomolybdate
GB201005394D0 (en) * 2010-03-30 2010-05-12 Magnus Intellectual Property Ltd Therapy
US8956393B2 (en) 2010-07-06 2015-02-17 Luis Edgardo Ramos Maza Devices, systems, and methods for acetabulum repair
WO2014152207A1 (en) 2013-03-15 2014-09-25 Mylan Laboratories, Inc. Hot melt granulation formulations of poorly water-soluble active agents
WO2017049529A1 (en) * 2015-09-24 2017-03-30 Innolife Co., Ltd. A pharmaceutical composition comprising a copper chelating tetramine and the use thereof
CN114394904A (en) 2018-05-04 2022-04-26 奥法兰股份公司 Crystalline forms of triethylenetetramine tetrahydrochloride and their pharmaceutical use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147070A (en) * 1998-06-05 2000-11-14 Facchini; Francesco Methods and compositions for controlling iron stores to treat and cure disease states

Also Published As

Publication number Publication date
WO2004017957A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2003214725A1 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003297356A1 (en) Prevention and treatment of cardiac arrhythmias
AU2003222513A1 (en) Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure
AU2003241347A1 (en) Medical catheter assembly and method of using the same
EP1573045A4 (en) Heart failure gene determination and therapeutic screening
AU2003214775A1 (en) Physiologically compatible cardiac assist device and method
EP1596868A4 (en) Method for treating severe heart failure and medicament therefor
AU2002367023A1 (en) Compositions and methods for treating heart failure
EP1434876A4 (en) Expression profiling in the intact human heart
EP1635801A4 (en) Methods for treating and preventing cardiac arrhythmia
AU2003291536A1 (en) Method for the diagnosis and treatment of vascular disease
AU2003252182A1 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
AU2002365057A1 (en) Compositions and methods for treating heart failure
PL375893A1 (en) Treatment of chronic heart failure
AU2003232115A1 (en) Methods and compositions for the treatment of graft failure
AU2003224956A1 (en) Reference structures and reference structure enhanced tomography
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
AU2003269944A1 (en) Mechanisms of myoblast transfer in treating heart failure
PT1487431E (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
AU2003245674A1 (en) Oral disease prevention and treatment
AU2003239844A1 (en) Bioartificial skin comprising genetically modified fibroblasts
AU2003248679A1 (en) Treating disease using radium-225

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase